CNS Pharmaceuticals, Inc. (CNSP) › Shareholders' EquityCNS Pharmaceuticals, Inc. (CNSP) — Shareholders' EquityAnnual figures by period end, from SEC filings.2017-12-31: -$58.5K2018-12-31: -$549.3K2019-12-31: $7.60M2020-12-31: $13.95M2021-12-31: $6.16M2022-12-31: $8.13M2023-12-31: -$4.43M2024-12-31: $6.18M2025-12-31: $4.52M$4.52M2017-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$4.52M-26.8%2026-03-31Balance as of period end2024-12-31$6.18M—2026-03-31Balance as of period end2023-12-31-$4.43M-154.5%2026-03-31Balance as of period end2022-12-31$8.13M+32.0%2025-03-31Balance as of period end2021-12-31$6.16M-55.8%2024-04-01Balance as of period end2020-12-31$13.95M+83.5%2023-03-31Balance as of period end2019-12-31$7.60M—2022-03-03Balance as of period end2018-12-31-$549.3K—2021-02-12Balance as of period end2017-12-31-$58.5K—2020-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)